Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
121M
-
Number of holders
-
85
-
Total 13F shares, excl. options
-
92.3M
-
Shares change
-
+16.4M
-
Total reported value, excl. options
-
$656M
-
Value change
-
+$109M
-
Put/Call ratio
-
1.32
-
Number of buys
-
48
-
Number of sells
-
-47
-
Price
-
$7.11
Significant Holders of Immatics N.V. - COMMON STOCK (IMTX) as of Q4 2024
116 filings reported holding IMTX - Immatics N.V. - COMMON STOCK as of Q4 2024.
Immatics N.V. - COMMON STOCK (IMTX) has 85 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 92.3M shares
of 121M outstanding shares and own 76.02% of the company stock.
Largest 10 shareholders include T. Rowe Price Investment Management, Inc. (10.6M shares), WELLINGTON MANAGEMENT GROUP LLP (10.4M shares), PERCEPTIVE ADVISORS LLC (9.38M shares), BAKER BROS. ADVISORS LP (7.28M shares), RTW INVESTMENTS, LP (6.54M shares), Vestal Point Capital, LP (6.28M shares), Paradigm Biocapital Advisors LP (5.41M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (5.07M shares), BRAIDWELL LP (3.5M shares), and ORBIMED ADVISORS LLC (3.09M shares).
This table shows the top 85 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.